NCT01243632View on ClinicalTrials.gov

Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Malignant Pleural Mesothelioma
Interventions
DRUG

Prolonged 6-hr infusion of gemcitabine

Gemcitabine 250 mg/m2 in prolonged 6 hr infusion on day 1 and 8, and cisplatin at 75 mg/m2 on day 2 of 3 week cycle, for 4-6 cycles

Trial Locations (1)

1000

Institute of Oncology Ljubljana, Ljubljana

All Listed Sponsors
collaborator

Ministry of Higher Education, Science and Technology, Solvenia

OTHER_GOV

lead

Institute of Oncology Ljubljana

OTHER

NCT01243632 - Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment | Biotech Hunter | Biotech Hunter